Q2 EPS Estimates for Viking Therapeutics Reduced by B. Riley
Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) – Investment analysts at B. Riley cut their Q2 2025 earnings per share (EPS) estimates for Viking Therapeutics in a research note issued on Thursday, April 24th. B. Riley analyst M. Mamtani now expects that the biotechnology company will earn ($0.43) per share for the quarter, down from […]
Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) – Investment analysts at B. Riley cut their Q2 2025 earnings per share (EPS) estimates for Viking Therapeutics in a research note issued on Thursday, April 24th. B. Riley analyst M. Mamtani now expects that the biotechnology company will earn ($0.43) per share for the quarter, down from […]
